Effect of Xuesaitong soft capsule on hemorrheology and in auxiliarily treating patients with acute cerebral infarction

Zhong Shang-qian; Sun Li-jing; Yan Yu-zhen; Sun Yan-qin; Zhong Yin-yuan

doi:10.1007/BF02836469

Your Location：

Home >

Browse articles >

Effect of Xuesaitong soft capsule on hemorrheology and in auxiliarily treating patients with acute cerebral infarction

OriginalPaper | Updated：2021-08-27

- Effect of Xuesaitong soft capsule on hemorrheology and in auxiliarily treating patients with acute cerebral infarction
- Effect of Xuesaitong soft capsule on hemorrheology and in auxiliarily treating patients with acute cerebral infarction
- 中国结合医学杂志（英文版） 2005年11卷第2期页码：128-131
- Affiliations：
  
  The Second People’s Hospital of Liaocheng,Shandong
- Author bio：
- Funds：
- DOI：10.1007/BF02836469
  中图分类号：
- 纸质出版日期：2005，
Scan for full text
Shang-qian, Z., Li-jing, S., Yu-zhen, Y. et al. Effect of Xuesaitong soft capsule on hemorrheology and in auxiliarily treating patients with acute cerebral infarction., Chin. J. Integr. Med. 11, 128–131 (2005). https://doi.org/10.1007/BF02836469

Zhong Shang-qian, Sun Li-jing, Yan Yu-zhen, et al. Effect of Xuesaitong soft capsule on hemorrheology and in auxiliarily treating patients with acute cerebral infarction[J]. Chinese Journal of Integrative Medicine, 2005,11(2):128-131.
Shang-qian, Z., Li-jing, S., Yu-zhen, Y. et al. Effect of Xuesaitong soft capsule on hemorrheology and in auxiliarily treating patients with acute cerebral infarction., Chin. J. Integr. Med. 11, 128–131 (2005). https://doi.org/10.1007/BF02836469 DOI：

Zhong Shang-qian, Sun Li-jing, Yan Yu-zhen, et al. Effect of Xuesaitong soft capsule on hemorrheology and in auxiliarily treating patients with acute cerebral infarction[J]. Chinese Journal of Integrative Medicine, 2005,11(2):128-131. DOI： 10.1007/BF02836469.

摘要

Objective: To observe the therapeutic effect of Xuesaitong soft capsule (XST and its effect on platelet counts

coagulation factor 1 (CF1) as well as hemorrheologic indexes in treating patients with acute cerebral infarction (ACI).Methods: Two hundred and four patients with ACI were assigned into two groups

the control group (n = 96) and the treated group (n = 108). They were all treated with conventional Western medicines

including mannitol

troxerutin

citicoline

piracetam and aspirin

while to the treated group

XST was given additionally through oral intake

twice a day

2 capsules each time for 8 successive weeks. The clinical efficacy was evaluated according to the nerve function deficits scoring and the changes of platelet count. CF1 and hemorrheological indexes were measured before and after treatment.Results: The total effective rate was 87.0% in the treated group

and 87. 5% in the control group

respectively

showing insignificant difference between them. But the markedly effective rate in the treated group (66.7%) was significantly higher than that in the control group (27.1%

P<0. 01). The count of platelet was not changed significantly in both groups after treatment

while CF1 in them evidently lowered at the end of the 4th and 8th weeks of treatment

but showed insignificant difference between the two groups. The hematocrit

whole blood viscosity and plasma viscosity in both groups were all improved significantly after treatment

but also showed insignificant difference in comparison of the two groups.Conclusion: XST has good efficacy in auxiliary treatment of patients with ACI

though its mechanism remains to be further explored.

Abstract

Objective: To observe the therapeutic effect of Xuesaitong soft capsule (XST and its effect on platelet counts

coagulation factor 1 (CF1) as well as hemorrheologic indexes in treating patients with acute cerebral infarction (ACI).Methods: Two hundred and four patients with ACI were assigned into two groups

the control group (n = 96) and the treated group (n = 108). They were all treated with conventional Western medicines

including mannitol

troxerutin

citicoline

piracetam and aspirin

while to the treated group

XST was given additionally through oral intake

twice a day

and 87. 5% in the control group

respectively

showing insignificant difference between them. But the markedly effective rate in the treated group (66.7%) was significantly higher than that in the control group (27.1%

P<0. 01). The count of platelet was not changed significantly in both groups after treatment

while CF1 in them evidently lowered at the end of the 4th and 8th weeks of treatment

but showed insignificant difference between the two groups. The hematocrit

whole blood viscosity and plasma viscosity in both groups were all improved significantly after treatment

but also showed insignificant difference in comparison of the two groups.Conclusion: XST has good efficacy in auxiliary treatment of patients with ACI

though its mechanism remains to be further explored.

关键词

Xuesaitong soft capsulenerve function deficits scoringhemorrheologic indexesacute cerebral infarction

Keywords

Xuesaitong soft capsulenerve function deficits scoringhemorrheologic indexesacute cerebral infarction

references

Li LX, Wang ZC, Huang ZH, et al. Protective action of notoginseng saponins against acute cerebral ischemia. Chin Pharmacol Bull 1991; 7(1): 56–58.

Bai Y, Zhang SY, Ren J, et al. Multi-center study on the notoginseng saponin in treating cerebral infarction. Chin J New Drugs Clin Remedies 2001; 20(4): 257–259.

Dong L. Clinical observation on treatment of unstable angina pectoris by Xuesaitong soft capsule combined with low molecular heparin. Chin J Integr Tradit West Med (Chin) 2004; 24(9): 789.

Chen QT. Standard for scoring of clinical nerve function deficits in patients with stroke (1995). Chin J Neurol 1996; 29: (4): 381–383.

The international stroke trial: A randomized trial of aspirin, subcutaneous heparin, both, or neither among 19435 patients with acute ischemic stroke. Lancet 1997; 349: 1569–1581.

Chinese acute stroke trial: Randomized placebo-controlled trial of early aspirin use in 20000 patients with acute ischemic stroke. Lancet 1997; 349: 1641–1649.

Van de Wert F, Topol EJ, Lee KL, et al. Global utilization of stroptokinase and tissue plasminogen activator for occluded coronary arteries. JAMA 1995; 273: 1586–1591.

Gulati M, Patel S, Jaffe AS, et al. Impact of contemporary guideline compliance for acute coronary syndromes. Am J Cardiol 2004; 94: 873–878.

Ai WB, Chen YH, Yang WJ. Clinical observation on treatment of serious cranial trauma by Xuesaitong injection combined with western medicines. Chin J Integr Tradit West Med 2004; 23(3): 213–215.

Cheng GL, Xun Y, Lu YT, et al. Effect of notoginseng saponins on serum vascular endothelial growth factor in patients with acute cerebral infarction. Chin J New Drugs Clin Remedies 2003; 22(6): 350–353.

Zhang YG, Lin TP. Protective effects of total saponins of Panax ginseng on ischemia reperfusion injury in rats brain. Chin Pharm Toxicol 1994; 11: 7–9.

Li LX. Protective effect of notoginseng saponins on rabbits with acute cerebral ischemia. Chin J Neurol Psychiatry 1987; (20): 109.

FULL TEXT LINK

More>

浏览量

506

Downloads

CSCD

文章被引用时，请邮件提醒。

Submit

工具集

关联资源

Clinical observation of the effect of Xuesaitong soft capsule on post-hepatitis fibrosis

Effect of the principle of activating blood circulation to break stasis on GMP-140 and D2 dimer in patients with acute cerebral infarction

Study of interference treatment by Xuesaitong soft capsule on patients of nephrosis syndrome with Qi deficiency and blood stasis during dose reducing stage of corticosteroid

Effect of Tongxinluo capsule on plasma endothelin, calcitonin gene-related peptide and nitrogen oxide of acute cerebral infarction patients

Clinical study on effect of Shenmai Injection in treating congestive heart failure